These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 27300108)

  • 1. Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer.
    Ankeny JS; Court CM; Hou S; Li Q; Song M; Wu D; Chen JF; Lee T; Lin M; Sho S; Rochefort MM; Girgis MD; Yao J; Wainberg ZA; Muthusamy VR; Watson RR; Donahue TR; Hines OJ; Reber HA; Graeber TG; Tseng HR; Tomlinson JS
    Br J Cancer; 2016 Jun; 114(12):1367-75. PubMed ID: 27300108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Tumor Cells Predict Occult Metastatic Disease and Prognosis in Pancreatic Cancer.
    Court CM; Ankeny JS; Sho S; Winograd P; Hou S; Song M; Wainberg ZA; Girgis MD; Graeber TG; Agopian VG; Tseng HR; Tomlinson JS
    Ann Surg Oncol; 2018 Apr; 25(4):1000-1008. PubMed ID: 29442211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating tumor cells found in patients with localized and advanced pancreatic cancer.
    Kulemann B; Pitman MB; Liss AS; Valsangkar N; Fernández-Del Castillo C; Lillemoe KD; Hoeppner J; Mino-Kenudson M; Warshaw AL; Thayer SP
    Pancreas; 2015 May; 44(4):547-50. PubMed ID: 25822154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KRAS mutations in pancreatic circulating tumor cells: a pilot study.
    Kulemann B; Liss AS; Warshaw AL; Seifert S; Bronsert P; Glatz T; Pitman MB; Hoeppner J
    Tumour Biol; 2016 Jun; 37(6):7547-54. PubMed ID: 26684803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
    Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
    World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutant
    Perets R; Greenberg O; Shentzer T; Semenisty V; Epelbaum R; Bick T; Sarji S; Ben-Izhak O; Sabo E; Hershkovitz D
    Oncologist; 2018 May; 23(5):566-572. PubMed ID: 29371474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Tumor Cells as a Biomarker in Pancreatic Ductal Adenocarcinoma.
    Liu H; Sun B; Wang S; Liu C; Lu Y; Li D; Liu X
    Cell Physiol Biochem; 2017; 42(1):373-382. PubMed ID: 28558380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTC phenotyping for a preoperative assessment of tumor metastasis and overall survival of pancreatic ductal adenocarcinoma patients.
    Sun Y; Wu G; Cheng KS; Chen A; Neoh KH; Chen S; Tang Z; Lee PF; Dai M; Han RPS
    EBioMedicine; 2019 Aug; 46():133-149. PubMed ID: 31375425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating tumor cells (Ctc) and kras mutant circulating free Dna (cfdna) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer.
    Earl J; Garcia-Nieto S; Martinez-Avila JC; Montans J; Sanjuanbenito A; Rodríguez-Garrote M; Lisa E; Mendía E; Lobo E; Malats N; Carrato A; Guillen-Ponce C
    BMC Cancer; 2015 Oct; 15():797. PubMed ID: 26498594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Portal Venous Blood Circulation Supports Immunosuppressive Environment and Pancreatic Cancer Circulating Tumor Cell Activation.
    Arnoletti JP; Zhu X; Almodovar AJ; Veldhuis PP; Sause R; Griffith E; Corpus G; Chang JC; Fanaian N; Litherland SA
    Pancreas; 2017 Jan; 46(1):116-123. PubMed ID: 27400259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterisation of circulating tumour cell phenotypes identifies a partial-EMT sub-population for clinical stratification of pancreatic cancer.
    Semaan A; Bernard V; Kim DU; Lee JJ; Huang J; Kamyabi N; Stephens BM; Qiao W; Varadhachary GR; Katz MH; Shen Y; San Lucas FA; Gascoyne P; Alvarez HA; Maitra A; Guerrero PA
    Br J Cancer; 2021 Jun; 124(12):1970-1977. PubMed ID: 33785875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of circulating tumor cells in patients with ampullary cancer.
    Sun B; Liu H; Wang S; Xiang J; Liu X
    J Cell Physiol; 2018 Jun; 233(6):5014-5022. PubMed ID: 29215725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A combination of circulating tumor cells and CA199 improves the diagnosis of pancreatic cancer.
    Chen J; Wang H; Zhou L; Liu Z; Tan X
    J Clin Lab Anal; 2022 May; 36(5):e24341. PubMed ID: 35334495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquisition of Portal Venous Circulating Tumor Cells From Patients With Pancreaticobiliary Cancers by Endoscopic Ultrasound.
    Catenacci DV; Chapman CG; Xu P; Koons A; Konda VJ; Siddiqui UD; Waxman I
    Gastroenterology; 2015 Dec; 149(7):1794-1803.e4. PubMed ID: 26341722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic circulating tumor cell detection by targeted single-cell next-generation sequencing.
    Yu J; Gemenetzis G; Kinny-Köster B; Habib JR; Groot VP; Teinor J; Yin L; Pu N; Hasanain A; van Oosten F; Javed AA; Weiss MJ; Burkhart RA; Burns WR; Goggins M; He J; Wolfgang CL
    Cancer Lett; 2020 Nov; 493():245-253. PubMed ID: 32896616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct serum metabolomics profiles associated with malignant progression in the KrasG12D mouse model of pancreatic ductal adenocarcinoma.
    LaConti JJ; Laiakis EC; Mays AD; Peran I; Kim SE; Shay JW; Riegel AT; Fornace AJ; Wellstein A
    BMC Genomics; 2015; 16 Suppl 1(Suppl 1):S1. PubMed ID: 25923219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of circulating tumour DNA in patients undergoing curative resection for pancreatic cancer.
    Hadano N; Murakami Y; Uemura K; Hashimoto Y; Kondo N; Nakagawa N; Sueda T; Hiyama E
    Br J Cancer; 2016 Jun; 115(1):59-65. PubMed ID: 27280632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Tumor Cells and Transforming Growth Factor Beta in Resected Pancreatic Adenocarcinoma.
    Vicente D; Lee AJ; Hall CS; Lucci A; Lee JE; Kim MP; Katz MHG; Hurd MW; Maitra A; Rhim Md AD; Tzeng CD
    J Surg Res; 2019 Nov; 243():90-99. PubMed ID: 31170555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical applications of circulating tumor DNA and circulating tumor cells in pancreatic cancer.
    Riva F; Dronov OI; Khomenko DI; Huguet F; Louvet C; Mariani P; Stern MH; Lantz O; Proudhon C; Pierga JY; Bidard FC
    Mol Oncol; 2016 Mar; 10(3):481-93. PubMed ID: 26856794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reality of Single Circulating Tumor Cell Sequencing for Molecular Diagnostics in Pancreatic Cancer.
    Court CM; Ankeny JS; Sho S; Hou S; Li Q; Hsieh C; Song M; Liao X; Rochefort MM; Wainberg ZA; Graeber TG; Tseng HR; Tomlinson JS
    J Mol Diagn; 2016 Sep; 18(5):688-696. PubMed ID: 27375074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.